Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sector of biopharmaceuticals, offering promising progress throughout many health-related and industrial purposes. With its structural similarity to Obviously derived human serum albumin, OsrHSA presents a safer,